Porovnat metody
Prohlédněte si vybrané metody vedle sebe; řádky, které se liší, jsou zvýrazněny.
| Bayesian Competing Risks Analysis× | Coxův model proporcionálních rizik× | |
|---|---|---|
| Obor | Epidemiologie | Epidemiologie |
| Rodina | Process / pipeline | Process / pipeline |
| Rok vzniku≠ | 1980s–2000s (classical CR: 1970s; Bayesian extension: 1990s–2000s) | 1972 |
| Tvůrce≠ | Various; Bayesian formulation advanced by Gelfand, Dey, Larson, and Dinse among others | Sir David Roxbee Cox |
| Typ≠ | Bayesian survival/time-to-event model | Semi-parametric regression model |
| Původní zdroj≠ | Larson, M. G., & Dinse, G. E. (1985). A mixture model for the regression analysis of competing risks data. Applied Statistics, 34(3), 201–211. DOI ↗ | Cox, D. R. (1972). Regression models and life-tables. Journal of the Royal Statistical Society: Series B (Methodological), 34(2), 187–202. DOI ↗ |
| Další názvy | Bayesian cause-specific hazard model, Bayesian subdistribution hazard model, BCRA, Bayesian cumulative incidence analysis | Cox regression, Cox PH model, proportional hazards model, CPH |
| Příbuzné≠ | 3 | 5 |
| Shrnutí≠ | Bayesian competing risks analysis is a time-to-event method for settings where subjects can fail from more than one mutually exclusive cause — such as death from cancer versus death from cardiovascular disease — and prior knowledge or small-sample uncertainty makes a Bayesian framework advantageous. It extends classical competing risks models (cause-specific hazards and cumulative incidence functions) by placing probability distributions over unknown parameters and updating those distributions with observed data, yielding full posterior inference for each failure type. | The Cox proportional hazards model is a semi-parametric regression method that estimates the effect of one or more covariates on the hazard — the instantaneous rate of an event such as death, relapse, or failure — while making no assumption about the shape of the baseline hazard function. Introduced by David Cox in 1972, it is the dominant tool for multivariable survival analysis in clinical and epidemiological research. |
| ScholarGateDatová sada ↗ |
|
|